| TG to HDL-C ratio |
This study aimed to develop a simplified screening model to identify pregnant Ch… |
Serum |
GDM(n=272),Normal Glucose Tolerance(n=1017)
|
Enzymatic Methods |
6th to 12th gestational weeks |
logistic regression |
A Simplified Screening Model to Predict the Risk of Gestational Diabetes Mellitus in Pregnant Chinese Women |
2023 |
Diabetes Therapy |
37843770 |
Risk factor |
| TG to HDL-C ratio |
This study evaluated the predictive effects of early pregnancy lipid profiles an… |
Serum |
GDM=1062,NGDM=4203;p-BMI<18.5(%) NGDM=621 GDM=89 ,18.5–23.9 (%) NGDM=2896 GDM=645 ,24–27.9 (%) NGDM=522 GDM=245,≥28 (%) NGDM=129 GDM=76
|
Enzymatic Methods |
before 14th gestational weeks |
|
The Predictive Effects of Early Pregnancy Lipid Profiles and Fasting Glucose on the Risk of Gestational Diabetes Mellitus Stratified by Body Mass Index |
2016 |
Journal of Diabetes Research |
26981541 |
Risk factor |
| RBP4 |
Retinol-binding protein 4 (RBP4), an adipocyte-derived factor, plays a pivotal r… |
|
|
|
|
|
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes |
2005 |
Nature |
16034410 |
Mechanism |
| ALP |
This study aimed to investigate the relationship between maternal liver biomarke… |
Serum |
GDM(n=1668),Normal Glucose Tolerance(n=7480)(ALP,Q1:15-43,Q2:44-50,Q3:51-57,Q4:58-139)
|
Colorimetric Method |
8th to 14th gestational weeks |
|
The associations of maternal liver biomarkers in early pregnancy with the risk of gestational diabetes mellitus: a prospective cohort study and Mendelian randomization analysis |
2024 |
Frontiers in Endocrinology |
38836232 |
Risk factor |
| ALT |
This study investigated the relationship between alanine aminotransferase (ALT)… |
Serum |
GDM(n=1332),Normal Glucose Tolerance(n=16027)
|
Enzymatic Methods |
4th to 12th gestational weeks |
|
Plasma Levels of Alanine Aminotransferase in the First Trimester Identify High Risk Chinese Women for Gestational Diabetes |
2016 |
Scientific Reports |
27264612 |
Risk factor |
| FABP4 |
Lipids play a fundamental role in cellular processes and disease pathogenesis, y… |
|
|
|
|
|
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets |
2008 |
Nat Rev Drug Discov |
18511927 |
Mechanism |
| FABP4 |
This study examined the association between first-trimester plasma fatty acid-bi… |
Plasma |
GDM(n=135),Normal Glucose Tolerance(n=1015)
|
ELISA |
First prenatal visit |
Logistic Regression,Quartile Analysis |
First-Trimester Serum Fatty Acid-Binding Protein 4 and Subsequent Gestational Diabetes Mellitus |
2017 |
Obstetrics And Gynecology |
29016489 |
Risk factor |
| FABP4 |
Fatty acid-binding protein 4 (FABP4), predominantly expressed in adipocytes, mon… |
|
|
|
|
|
A New Insight into Fatty Acid Binding Protein 4 Mechanisms and Therapeutic Implications in Obesity-Associated Diseases: A Mini Review |
2024 |
Mol Nutr Food Res |
38593305 |
Mechanism |
| FABP4 |
This study aimed to evaluate the diagnostic potential of fatty acid-binding prot… |
Serum |
GDM(n=46),Normal Glucose Tolerance(n=55)
|
ELISA |
23th to 30th gestational weeks |
|
Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus |
2016 |
Acta Diabetologica |
27147422 |
Risk factor |
| FABP4 |
This study investigated the role of fatty acid-binding protein 4 (FABP4) in insu… |
Plasma |
GDM(n=135),Normal Glucose Tolerance(n=135)
|
ELISA |
before 14th gestational weeks & 25th to 28th gestational weeks |
|
Risk of Gestational Diabetes Mellitus in relation to Plasma Concentrations of Fatty Acid-Binding Protein 4: A Nested Case-Control Study in China |
2021 |
Journal of Diabetes Research |
34368366 |
Risk factor |